Get the latest news, insights, and market updates on EXPO (Exponent, Inc.). Explore the news page 5 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
EchoStar, Lumen, Exponent, TD SYNNEX, and IBM Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official hinted at a potential interest rate cut in December. John Williams, president of the Federal Reserve Bank of New York, signaled he was open to lowering the fed funds rate—the key interest rate that banks charge each other for overnight loans—to support the job market. Speaking at an event, Williams stated that he sees “room for a further adjustment” for interest rates, which immediately shifted Nov 21, 2025 - $EXPO
1 Small-Cap Stock with Promising Prospects and 2 That Underwhelm
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets. Nov 21, 2025 - $EXPO
How the Narrative Around Exponent Is Evolving After Recent Analyst Updates
Exponent’s fair value estimate holds steady at $83, while the discount rate has inched higher to approximately 7.18 percent. These recent adjustments reflect a mix of optimism around artificial intelligence-driven growth and caution regarding sector-wide automation risks. Revenue growth forecasts remain unchanged at 7.01 percent. Stay tuned to see how investors and analysts can track evolving factors shaping Exponent’s valuation narrative going forward. Analyst Price Targets don't always... Nov 19, 2025 - $EXPO
3 Reasons to Sell EXPO and 1 Stock to Buy Instead
Over the past six months, Exponent’s shares (currently trading at $69.95) have posted a disappointing 12.5% loss, well below the S&P 500’s 13% gain. This may have investors wondering how to approach the situation. Nov 17, 2025 - $EXPO
Truist Maintains Buy Rating on Exponent (EXPO) While Cutting Price Target to $90
Exponent, Inc. (NASDAQ:EXPO) is included among the 15 Overlooked Dividend Stocks to Buy Right Now. On November 2, Truist lowered its price target for Exponent, Inc. (NASDAQ:EXPO) from $100 to $90 while maintaining a Buy rating, according to a report by The Fly. The analyst noted that artificial intelligence could create new opportunities for the […] Nov 12, 2025 - $EXPO
The 5 Most Interesting Analyst Questions From Exponent’s Q3 Earnings Call
Exponent’s third quarter performance was led by robust demand for its dispute-related consulting work, particularly in the energy, transportation, life sciences, and construction sectors. Management highlighted that reactive projects—those addressing urgent client challenges such as litigation or failure analysis—were the primary growth driver, while proactive risk management and regulatory consulting also contributed, especially in utilities and chemicals. CEO Catherine Corrigan noted, “Our div Nov 6, 2025 - $EXPO
3 of Wall Street’s Favorite Stocks We Find Risky
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory. Nov 3, 2025 - $EXPO
Exponent (EXPO) Profit Margins Decline, Challenging Premium Valuation Narrative
Exponent (EXPO) posted net profit margins of 19.8%, down from 20.6% last year, signaling a marginal contraction in profitability. While the company has grown earnings at a 4% annual rate over the past five years, the forward outlook calls for earnings growth of 13.2% per year and revenue growth of 6.8% per year. Both are somewhat slower than US market averages. For investors, the latest numbers highlight steady albeit modest growth, with Exponent’s continued appeal stemming from past earnings... Nov 1, 2025 - $EXPO
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple